Living with Hope After an ATTR-Cardiac Amyloidosis (ATTR-CM) Diagnosis

Jun 18, 2026

News

Left atrioventricular coupling index in transthyretin amyloid cardiomyopathy: Association with mortality

Jul 25, 2026

A Retrospective Analysis of Clinical Presentation, Diagnosis, and Treatment Outcomes in hATTR Polyneuropathy (P7-9.006)

Jul 14, 2026

Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM

Jul 02, 2026

BridgeBio Pharma Announces New Circulation: Heart Failure Analyses Showing Kidney-Protective Effects of Acoramidis in ATTR-CM

Jul 02, 2026

Nuclear Medicine Department at FV Hospital publishes diagnostic approach for a “hard-to-detect” heart condition in the Journal of Health and Ageing (JHA)

Jul 02, 2026

More in News

Education

Systemic Amyloidosis

Jul 30, 2026

Acoramidis shows early and sustained kidney-protective effects in ATTR-CM patients, improving heart and kidney health.

Jul 02, 2026

Cardiac amyloidosis: Better detection and new treatments

Jul 01, 2026

Using AI Echo to Detect Cardiac Amyloidosis Early: Us2.ai Webinar with Studycast

Jul 01, 2026

2026 HFM CME Symposium - Overcoming Challenges in Transthyretin Cardiac Amyloidosis

Jul 01, 2026

More in Education

Community Center

MUST WATCH VIDEO ... Cardiac Amyloidosis - AL and ATTR: Two Different Conditions

Jul 25, 2026

Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies

Jul 25, 2026

Health's Post

Jul 02, 2026

Many heart failure patients are still not consistently identified early enough and – that gap matters

Jul 02, 2026

doctortim.md

Jul 01, 2026

More in Community Center

Video